
Below you can find publications of work that has been carried out within the Research Training Group Chembion.
2026
-
L. Flämig, W. F. Zhu, K. Hoffmann, C. Daniliuc, D. Schepmann, F. Glorius, M. Bermúdez, K. Loser, B. Wünsch. Diastereoselective synthesis of 1,4,8-trisubstituted perhydroquinolines as novel κ receptor agonists. Org. Biomol. Chem. 2026, 24,4627-4649. doi: 10.1039/d6ob00422a
- F. Roßner, T. Jepps, B. Hjorth Bentzen, N. Strutz-Seebohm, B. Wünsch, G. Seebohm. Electro-mechanical uncoupling of KV7.1 voltage sensor and pore by 1,4-benzodiazepines is modulated by decoration of position 1. Arch. Pharm. 2026, 359: e70305. doi: 10.1002/ardp.70305
- F. Roßner, J. Schmidt, G. Seebohm, B. Wünsch. Structure-activity relationship study on ligands activating the voltage-gated potassium channel KV7.1. Arch. Pharm. 2026, 359: e70268. doi: 10.1002/ardp.70268
- M. Korff, G. Goerges, J. Schmidt, D. Schepmann, G. Seebohm, J. Schreiber, B. Wünsch. Stereoselective synthesis of conformationally restricted γ- and β-amino alcohols as GluN2B subtype-selective NMDA receptor antagonists. J. Med. Chem. 2026, 69,1671-1697. doi: 10.1021/acs.jmedchem.5c03189
- A. Takhi, G. Seebohm, T. Budde, A. Lüttjohann. KV7 and K2P Potassium Channels in Thalamocortical Function and Their Therapeutic Potential in Childhood Absence Epilepsy. Arch. Pharm. 2026, 359: e70276. doi: 10.1002/ardp.70276
-
N. Rychlik, K. Jüngling, S. G. Meuth, T. Budde, M. Méndez-Couz. Channel Dysfunction as the Basis for Comorbidities in Multiple Sclerosis and Depression. Arch. Pharm. 2026, 359: e70273. doi: 10.1002/ardp.70273
-
D. Linhoff, M. Mertens, R. Zimmermann, S. Peischard, C. Brenker, T. Budde, S. Meuth, C. Gatsogiannis, A. Lüttjohann, L. Sosulina, J. Hescheler, N. Strutz-Seebohm†, G. Seebohm†. Aberrant TMPRSS6‐Protease Regulation of Disease Mutant HCN4–KCNE1 Channel Complex Depends on the KCNE1‐G38S Polymorphism. Arch. Pharm. 2026, 359:e70303. doi: 10.1002/ardp.70303 † These authors contributed equally to this work
-
E. Karabatak, R. Nematswerani†, V. Meiritz†, N. Rychlik, G. Seebohm, F. Glorius, T. Budde. Cholesterol and Cholesterol-Derived Molecules Differentially Modulate Neuronal Kv7.2/7.3 Channels. Arch. Pharm. 2026, 359: e70280. doi: 10.1002/ardp.70280 † These authors contributed equally to this work
-
N. Kock†, L. Heitzer†, J. Massa, M. Taterra, M. Bermúdez, O. Koch, M. Schiedel. BRET-Based Approaches for Ion Channels: Emerging Applications and Future Directions. Arch. Pharm. 2026, 359:e70325. doi: 10.1002/ardp.70325
† These authors contributed equally to this work -
M. Taterra, Y. Chang-Halabi, M. Bermúdez. Molecular Mechanism and Probe-Dependent Effects of Clinically Relevant GABAA Receptor Modulators. Arch. Pharm. 2026, 359:e70277. doi:10.1002/ardp.70277
-
F. Wendling, Y. Chang-Halabi, J. Schmidt, D. Schepmann, J. A. Schreiber, W. F. Zhu, M. Bermúdez, B. Wünsch. Negative allosteric modulation of NMDA receptors with GluN2B subunit: synthesis of γ-amino alcohols embedded in a 1-benzoxepine scaffold. RSC Med. Chem. 2026, 17(9):4347-4375. doi:10.1039/d6md00252h
-
